- Zinc is an essential trace nutrient in humans that plays a role in the immune system.
- Respiratory tract infections are common and produce a variety of symptoms ranging from mild to severe.
- According to a recent review and meta-analysis, zinc supplements might prevent and decrease the duration of respiratory tract infection symptoms.
Conditions that impact the respiratory system are common. Sometimes, their symptoms are mild, but in some cases, they are severe.
Researchers are constantly examining treatment options that could improve the symptoms, shorten their duration, or prevent them entirely.
- cell division and growth
- wound healing
- the sense of smell and taste
- breakdown of carbohydrates
- enhancement of insulin action
Foods that contain zinc include oysters, red meat, chicken, seafood, beans, nuts, whole grains, and dairy products. Multivitamins often include zinc. It is also available in nasal sprays and gels and some cold lozenges.
Most people in the United States derive enough zinc from the food they eat. However, researchers are still trying to determine the benefits of taking zinc as a supplement. Some scientists focus on how zinc might protect against viral infections.
The authors of the new study note that options to prevent or therapeutically treat viral respiratory tract infections are limited.
One option is vaccination, which is why health groups promote it.
For example, the Centers for Disease Control and Prevention (CDC) encouraged vaccination in a recent Facebook post: “To get the most protection against COVID-19 and flu this season, make sure you get vaccinated against both COVID-19 AND flu. You can get both shots in the same visit if the timing coincides!”
However, as the study authors note, “Except for influenza and SARS-CoV-2 vaccinations, prophylactic and therapeutic options are limited.”
For this reason, researchers are interested in treatments that might relieve symptoms or shorten the duration of respiratory tract infections.
The study in question is a rapid systematic review and meta-analysis that focused on randomized controlled trials.
The researchers identified studies that:
- included adults who were at risk of or had viral respiratory tract infections
- examined the use of zinc via any dose, route, or duration
- measured specific outcomes, such as the incidence of respiratory tract infections and symptom severity
Moreover, they specifically excluded studies that looked at zinc as a treatment with other medication interventions.
Using these criteria, the researchers examined 28 studies involving a total of 5,446 participants. None of the studies were specific to SARS-CoV-2.
Dr. Jennifer Hunter, Ph.D., one of the study authors, explained to Medical News Today that some of the studies they examined had not been included in previous systemic reviews:
“I was surprised that only one of the four studies that had evaluated prophylactic zinc had previously been identified and reported in systematic reviews. Two were published in Chinese, and this was a good reminder about why it is so important to search databases in languages other than English.”
The analysis generated mixed results. For example, the researchers found that:
- using oral or intranasal zinc prevented respiratory tract infections in some individuals
- symptoms of respiratory tract infections were resolved about 2 days earlier in people taking sublingual or intranasal zinc, compared with placebo
- taking zinc helped reduce symptom severity on the third day of evaluating intensity of symptoms
They found, however, that taking zinc did not impact average daily symptom severity. They also report an association between taking zinc and more adverse effects, such as nausea and gastrointestinal discomfort.
Overall, the authors conclude that for people who do not have zinc deficiency, taking zinc might help prevent viral respiratory tract infections and shorten the duration of their symptoms.
It is of note that the study had some limitations. First, the researchers point out that some of the studies had a potential for bias. Second, this particular analysis was a rapid analysis, meaning that some tasks were completed by only one reviewer. This increases the risk of error in analysis.
Finally, the authors note that none of the studies were specifically about people who had COVID-19 and that more research is necessary to determine whether taking zinc could help improve the symptoms of COVID-19.
Dr. Hunter explained to MNT that we are “now well into the pandemic and quickly learning that a lot of therapies that have worked for other viral infections don’t necessarily work for COVID-19. We cannot assume the results from these zinc studies apply to COVID-19.”
However, the results indicate that zinc may be beneficial for people who have respiratory tract infections. Dr. Hunter said:
“I wouldn’t necessarily rush out and start taking zinc, as there is the risk of copper deficiency with ongoing use. However, I would suggest that people with chronic diseases and older adults discuss their dietary zinc intake with their healthcare professionals.”